Phase II study of idelalisib, a selective inhibitor of PI3Kδ, for relapsed/refractory classical Hodgkin lymphoma
| Image |  |
|---|---|
| Description | scientific article published on 24 January 2017 |
| Author/s |
author: Ajay K Gopal Michelle A Fanale |
| Publication date | January 24, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |